STAAR Surgical Company
STAAR Surgical manufactures implantable ophthalmic devices with minimal direct government dependence and negligible political engagement.
BusinessWhat STAA does
STAAR Surgical designs and manufactures implantable contact lenses and other ophthalmic surgical devices for vision correction. Revenue derives primarily from direct sales to ophthalmology clinics and hospitals globally, with minimal Medicare/Medicaid exposure relative to larger medical device peers.
Executive Branch ConflictsSTAA held by Trump-administration officials
Lifetime Government AwardsSTAA federal contracts by year
Smart Money · 13F HoldingsHedge funds holding STAA
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting STAALive legislation impacting this stock
Political ProfileWhere STAA sits in Washington
STAAR has no measurable lobbying footprint, zero politician trades, and minimal regulatory exposure relative to larger medtech peers. Stock movement driven by clinical trial results and reimbursement decisions rather than legislative events.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA approval delays
- international regulatory divergence
Regulatory opportunities
- Medicare coverage expansion for implantable lenses
- FDA breakthrough device designation
Live signals + predictions for STAA — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades STAA
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord